Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

zSpace stock logo

1. zSpace NASDAQ:ZSPC

$3.06 +0.06 (+2.00%)
As of 07/3/2025 01:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$70.02 million
Consensus Rating
Buy
Consensus Price Target
$15.00 (+390.2% Upside)
Volume
22,028 shares
Average Volume
44,851 shares
Today's Range
$2.99
$3.29
OS Therapies stock logo

2. OS Therapies NYSE:OSTX

$1.87 -0.04 (-2.09%)
Closing price 07/3/2025 03:52 PM Eastern
Extended Trading
$1.88 +0.01 (+0.80%)
As of 07/3/2025 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$51.42 million
P/E Ratio
-2.17
Consensus Rating
Buy
Consensus Price Target
$18.00 (+862.6% Upside)
Volume
8.01 million shares
Average Volume
491,386 shares
TuHURA Biosciences stock logo

3. TuHURA Biosciences NASDAQ:HURA

$2.47 -0.14 (-5.36%)
Closing price 07/3/2025 03:52 PM Eastern
Extended Trading
$2.49 +0.02 (+0.81%)
As of 07/3/2025 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$108.33 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+412.8% Upside)
Volume
603,783 shares
Average Volume
264,632 shares
Today's Range
$2.15
$2.74
Telecom Italia stock logo

4. Telecom Italia OTCMKTS:TIIAY

$4.83 +0.09 (+1.90%)
As of 07/3/2025 12:50 PM Eastern

Telecom Italia S.p.A., together with its subsidiaries, engages in the provision of fixed and mobile telecommunications services in Italy and internationally. More about Telecom Italia

Consensus Rating
Buy
Volume
7,009 shares
Average Volume
18,331 shares
Today's Range
$4.81
$4.83
50-Day Range
$3.84
$4.90
52-Week Range
$2.19
$4.90
OnKure Therapeutics stock logo

5. OnKure Therapeutics NASDAQ:OKUR

$2.40 0.00 (0.00%)
Closing price 07/3/2025 01:33 PM Eastern
Extended Trading
$2.40 0.00 (0.00%)
As of 07/3/2025 04:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$32.15 million
P/E Ratio
-0.46
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,247.2% Upside)
Volume
38,896 shares
Average Volume
108,186 shares
Western Copper & Gold stock logo

6. Western Copper & Gold NYSE:WRN

$1.25 -0.03 (-2.34%)
As of 07/3/2025 03:30 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$250.29 million
P/E Ratio
-62.50
Consensus Rating
Buy
Consensus Price Target
$4.00 (+220.0% Upside)
Volume
180,175 shares
Average Volume
367,576 shares
Denison Mine stock logo

7. Denison Mine NYSEAMERICAN:DNN

$1.82 +0.01 (+0.55%)
As of 07/3/2025 05:00 PM Eastern

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization
$1.63 billion
P/E Ratio
-22.75
Consensus Rating
Buy
Consensus Price Target
$3.00 (+64.8% Upside)
Volume
45.24 million shares
Average Volume
50.06 million shares
MannKind stock logo

8. MannKind NASDAQ:MNKD

$3.60 -0.02 (-0.41%)
Closing price 07/3/2025 03:48 PM Eastern
Extended Trading
$3.61 +0.00 (+0.14%)
As of 07/3/2025 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. More about MannKind

Market Capitalization
$1.09 billion
P/E Ratio
36.05
Consensus Rating
Buy
Consensus Price Target
$10.33 (+186.6% Upside)
Volume
1.74 million shares
Average Volume
2.43 million shares
Reviva Pharmaceuticals stock logo

9. Reviva Pharmaceuticals NASDAQ:RVPH

$0.37 -0.02 (-4.42%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$0.37 0.00 (-0.27%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$17.28 million
P/E Ratio
-0.47
Consensus Rating
Buy
Consensus Price Target
$9.00 (+2,345.7% Upside)
Volume
2.14 million shares
Average Volume
1.35 million shares
GeoVax Labs stock logo

10. GeoVax Labs NASDAQ:GOVX

$0.48 +0.00 (+0.69%)
As of 07/3/2025 01:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$7.65 million
P/E Ratio
-0.13
Consensus Rating
Buy
Consensus Price Target
$11.10 (+2,212.0% Upside)
Volume
1.19 million shares
Average Volume
2.58 million shares
Quince Therapeutics stock logo

11. Quince Therapeutics NASDAQ:QNCX

$1.60 +0.01 (+0.31%)
As of 07/3/2025 03:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$73.21 million
P/E Ratio
-1.15
Consensus Rating
Buy
Consensus Price Target
$8.00 (+398.4% Upside)
Volume
138,723 shares
Average Volume
307,901 shares
Hochschild Mining stock logo

12. Hochschild Mining OTCMKTS:HCHDF

$3.73 +0.06 (+1.64%)
As of 07/3/2025 12:38 PM Eastern

Hochschild Mining plc, a precious metals company, engages in the exploration, mining, processing, and sale of gold and silver in the Americas. More about Hochschild Mining

Market Capitalization
$1.92 billion
Consensus Rating
Buy
Volume
29,738 shares
Average Volume
25,645 shares
Today's Range
$3.60
$3.73
50-Day Range
$3.20
$4.21
Rezolve AI stock logo

13. Rezolve AI NASDAQ:RZLV

$2.84 +0.08 (+2.71%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$2.82 -0.03 (-0.91%)
As of 07/3/2025 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$587.29 million
Consensus Rating
Buy
Consensus Price Target
$6.00 (+110.9% Upside)
Volume
4.67 million shares
Average Volume
5.62 million shares
Today's Range
$2.78
$2.90
Immunic stock logo

14. Immunic NASDAQ:IMUX

$0.73 +0.02 (+2.24%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$0.73 +0.00 (+0.27%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$69.68 million
P/E Ratio
-0.59
Consensus Rating
Buy
Consensus Price Target
$11.60 (+1,491.2% Upside)
Volume
635,541 shares
Average Volume
969,370 shares
Full House Resorts stock logo

15. Full House Resorts NASDAQ:FLL

$4.11 +0.02 (+0.39%)
As of 07/3/2025 03:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Full House Resorts, Inc owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. More about Full House Resorts

Market Capitalization
$150.38 million
P/E Ratio
-3.70
Consensus Rating
Buy
Consensus Price Target
$5.67 (+38.0% Upside)
Volume
124,158 shares
Average Volume
174,352 shares
Alumis stock logo

16. Alumis NASDAQ:ALMS

$3.28 +0.01 (+0.15%)
Closing price 07/3/2025 03:09 PM Eastern
Extended Trading
$3.36 +0.07 (+2.28%)
As of 07/3/2025 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Our mission is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. More about Alumis

Market Capitalization
$184.98 million
Consensus Rating
Buy
Consensus Price Target
$22.86 (+595.8% Upside)
Volume
444,413 shares
Average Volume
428,629 shares
Today's Range
$3.30
$3.50
Ur Energy stock logo

17. Ur Energy NYSEAMERICAN:URG

$1.09 +0.02 (+1.87%)
As of 07/3/2025 05:00 PM Eastern

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$397.65 million
P/E Ratio
-8.38
Consensus Rating
Buy
Consensus Price Target
$2.30 (+111.0% Upside)
Volume
2.35 million shares
Average Volume
4.66 million shares
Vizsla Silver stock logo

18. Vizsla Silver NYSE:VZLA

$2.98 0.00 (0.00%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$3.02 +0.04 (+1.17%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vizsla Silver Corp. engages in the exploration, and development of precious and base metal assets. The company explores for gold, silver, and copper deposits. More about Vizsla Silver

Market Capitalization
$986.90 million
P/E Ratio
-298.00
Consensus Rating
Buy
Consensus Price Target
$3.83 (+28.6% Upside)
Volume
3.67 million shares
Average Volume
2.05 million shares
Lucid Diagnostics stock logo

19. Lucid Diagnostics NASDAQ:LUCD

$1.09 +0.04 (+3.43%)
Closing price 07/3/2025 03:55 PM Eastern
Extended Trading
$1.08 0.00 (-0.09%)
As of 07/3/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid Diagnostics

Market Capitalization
$111.43 million
P/E Ratio
-0.81
Consensus Rating
Buy
Consensus Price Target
$3.55 (+226.9% Upside)
Volume
1.16 million shares
Average Volume
665,818 shares
Nuvation Bio stock logo

20. Nuvation Bio NYSE:NUVB

$2.08 +0.04 (+1.71%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$2.07 -0.02 (-0.72%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nuvation Bio Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. More about Nuvation Bio

Market Capitalization
$711.15 million
P/E Ratio
-0.89
Consensus Rating
Buy
Consensus Price Target
$7.17 (+243.7% Upside)
Volume
3.37 million shares
Average Volume
2.95 million shares
Electrovaya stock logo

21. Electrovaya NASDAQ:ELVA

$3.36 +0.06 (+1.66%)
As of 07/3/2025 01:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Electrovaya Inc engages in the design, development, manufacture, and sale of lithium-ion batteries, battery management systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications in North America. More about Electrovaya

Market Capitalization
$133.56 million
Consensus Rating
Buy
Consensus Price Target
$6.10 (+81.3% Upside)
Volume
12,448 shares
Average Volume
60,722 shares
Today's Range
$3.24
$3.38
United States Antimony stock logo

22. United States Antimony NYSE:UAMY

$2.22 +0.09 (+3.99%)
Closing price 07/3/2025 03:56 PM Eastern
Extended Trading
$2.22 +0.01 (+0.23%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. More about United States Antimony

Market Capitalization
$263.81 million
P/E Ratio
-55.38
Consensus Rating
Buy
Consensus Price Target
$3.38 (+52.4% Upside)
Volume
3.66 million shares
Average Volume
2.72 million shares
FibroBiologics stock logo

23. FibroBiologics NASDAQ:FBLG

$0.64 +0.03 (+4.72%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$0.64 0.00 (0.00%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$23.42 million
P/E Ratio
-3.04
Consensus Rating
Buy
Consensus Price Target
$13.00 (+1,934.4% Upside)
Volume
366,945 shares
Average Volume
302,011 shares
NRx Pharmaceuticals stock logo

24. NRx Pharmaceuticals NASDAQ:NRXP

$3.31 -0.01 (-0.30%)
Closing price 07/3/2025 03:44 PM Eastern
Extended Trading
$3.30 -0.01 (-0.42%)
As of 07/3/2025 04:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. More about NRx Pharmaceuticals

Market Capitalization
$58.44 million
P/E Ratio
-1.65
Consensus Rating
Buy
Consensus Price Target
$28.50 (+761.0% Upside)
Volume
93,865 shares
Average Volume
419,969 shares
Ovid Therapeutics stock logo

25. Ovid Therapeutics NASDAQ:OVID

$0.34 +0.01 (+4.08%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$0.35 +0.01 (+2.91%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization
$24.06 million
P/E Ratio
-0.98
Consensus Rating
Buy
Consensus Price Target
$3.13 (+808.4% Upside)
Volume
283,192 shares
Average Volume
434,142 shares